X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8412) 8412
Book Review (1283) 1283
Publication (692) 692
Newsletter (185) 185
Newspaper Article (59) 59
Book Chapter (57) 57
Book / eBook (24) 24
Magazine Article (23) 23
Conference Proceeding (15) 15
Transcript (6) 6
Reference (5) 5
Dissertation (4) 4
Trade Publication Article (4) 4
Paper (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7392) 7392
humans (4877) 4877
male (4144) 4144
animals (3588) 3588
purines (3507) 3507
sildenafil citrate (2556) 2556
female (2071) 2071
middle aged (1504) 1504
rats (1493) 1493
adult (1388) 1388
sildenafil (1320) 1320
pharmacology & pharmacy (1255) 1255
sulfones (1199) 1199
purines - pharmacology (1156) 1156
piperazines - therapeutic use (1147) 1147
mice (1143) 1143
aged (984) 984
purines - administration & dosage (974) 974
piperazines - administration & dosage (941) 941
purines - therapeutic use (882) 882
treatment outcome (825) 825
analysis (809) 809
piperazines - pharmacology (799) 799
erectile dysfunction - drug therapy (787) 787
dose-response relationship, drug (729) 729
abridged index medicus (699) 699
erectile dysfunction (697) 697
neurosciences (674) 674
research (623) 623
biochemistry & molecular biology (602) 602
urology & nephrology (558) 558
physiological aspects (553) 553
administration, oral (552) 552
oncology (542) 542
sulfones - therapeutic use (539) 539
phosphodiesterase inhibitors - therapeutic use (517) 517
time factors (517) 517
purines - metabolism (516) 516
care and treatment (511) 511
drug therapy (511) 511
piperazines - adverse effects (504) 504
oxidative stress (501) 501
cardiac & cardiovascular systems (500) 500
adenosine (499) 499
nitric oxide (494) 494
sulfones - administration & dosage (480) 480
rats, sprague-dawley (476) 476
disease models, animal (475) 475
health aspects (474) 474
rats, wistar (463) 463
metabolism (462) 462
vasodilator agents - administration & dosage (454) 454
cancer (452) 452
purines - adverse effects (447) 447
impotence (439) 439
nitric-oxide (437) 437
vasodilator agents - therapeutic use (436) 436
sulfones - pharmacology (420) 420
medicine & public health (415) 415
therapy (412) 412
hypertension, pulmonary - drug therapy (406) 406
article (392) 392
enzymes (391) 391
phosphodiesterase inhibitors - pharmacology (386) 386
apoptosis (381) 381
oxidases (365) 365
expression (361) 361
cell biology (355) 355
double-blind method (355) 355
drug therapy, combination (355) 355
niacinamide (354) 354
phosphodiesterase inhibitors - administration & dosage (352) 352
rodents (345) 345
hypertension (328) 328
proteins (324) 324
cells (313) 313
phosphates (310) 310
physiology (300) 300
pulmonary hypertension (297) 297
in-vitro (295) 295
adolescent (293) 293
toxicology (292) 292
risk factors (289) 289
double-blind (287) 287
inflammation (285) 285
men (282) 282
purine (282) 282
safety (280) 280
dosage and administration (278) 278
endocrinology & metabolism (276) 276
medicine, research & experimental (276) 276
activation (275) 275
mice, inbred c57bl (271) 271
inhibition (268) 268
metabolites (267) 267
gout (264) 264
oral sildenafil (264) 264
brain (263) 263
medicine (260) 260
efficacy (259) 259
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8434) 8434
German (114) 114
Japanese (34) 34
French (33) 33
Spanish (29) 29
Russian (28) 28
Chinese (24) 24
Italian (16) 16
Hungarian (8) 8
Polish (7) 7
Danish (5) 5
Swedish (5) 5
Norwegian (4) 4
Turkish (4) 4
Ukrainian (4) 4
Dutch (3) 3
Portuguese (3) 3
Czech (2) 2
Slovak (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 08/2015, Volume 21, Issue 16, pp. 3705 - 3715
Purpose: Bruton's tyrosine kinase (BTK) is a critical enzyme in the B-cell receptor pathway and is inhibited by ibrutinib due to covalent binding to the kinase... 
B-CELL RECEPTOR | TUMOR PROLIFERATION | BRUTONS TYROSINE KINASE | CLL | ONCOLOGY | BCL-2 INHIBITOR | INITIAL THERAPY | IN-VIVO | PCI-32765 | KINASE INHIBITOR IBRUTINIB | SINGLE-ARM | Piperazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Apoptosis - drug effects | Humans | Neoplastic Cells, Circulating - metabolism | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Purines - administration & dosage | Bendamustine Hydrochloride - administration & dosage | Protein-Tyrosine Kinases - genetics | Female | bcl-X Protein - biosynthesis | Protein-Tyrosine Kinases - biosynthesis | B-Cell Activating Factor - biosynthesis | Neoplastic Cells, Circulating - drug effects | Pyrimidines - administration & dosage | Gene Expression Regulation, Leukemic - drug effects | Nitrophenols - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - biosynthesis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Pyrazoles - administration & dosage | B-Cell Activating Factor - genetics | Biphenyl Compounds - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Isoquinolines - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - genetics | Sulfonamides - administration & dosage | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2010, Volume 55, Issue 18, pp. 1915 - 1922
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 10/2008, Volume 149, Issue 8, pp. 521 - 530
Background: Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension.... 
INHALED ILOPROST | SURVIVAL | MEDICINE, GENERAL & INTERNAL | ORAL SILDENAFIL | EFFICACY | TREPROSTINIL | SAFETY | COMBINATION THERAPY | PROSTACYCLIN | BOSENTAN | Piperazines - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Sulfones - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension, Pulmonary - physiopathology | Male | Dyspepsia - chemically induced | Purines - administration & dosage | Hemodynamics - physiology | Walking - physiology | Sildenafil Citrate | Time Factors | Epoprostenol - adverse effects | Adult | Female | Hypertension, Pulmonary - drug therapy | Purines - adverse effects | Drug Therapy, Combination | Headache - chemically induced | Double-Blind Method | Administration, Oral | Piperazines - adverse effects | Antihypertensive Agents - adverse effects | Adolescent | Quality of Life | Aged | Vasodilator Agents - adverse effects | Hypertension, Pulmonary - etiology | Vasodilator Agents - administration & dosage | Epoprostenol - administration & dosage | Sulfones - administration & dosage | Complications and side effects | Epoprostenol | Dosage and administration | Sildenafil | Drug therapy, Combination | Research | Drug therapy | Pulmonary hypertension | Hypertension | Inhibitor drugs | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 384 - 393
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 07/2018, Volume 19, Issue 7, pp. 904 - 915
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2012, Volume 157, Issue 10, pp. 681 - 691
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2012, Volume 53, Issue 7, pp. 1431 - 1439
Journal Article
Hepatology, ISSN 0270-9139, 07/2014, Volume 60, Issue 1, pp. 56 - 64
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2014, Volume 171, Issue 7, pp. 1735 - 1746
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article